CLINICAL_TRIALS ClinicalTrials.gov record update

Phase IIIb Immunogenicity, Safety and Reactogenicity Study of GSK Biologicals' Meningococcal Vaccine [GSK 134612] When Given as One Dose to Healthy Subjects Aged 56 Years or Older

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01235975
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:49.538242+00:00
Published At: 2017-04-28T00:00:00+00:00
Record Updated At: 2018-08-20
Results Posted At: 2017-04-28
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Infections, Meningococcal"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-08-20"
protocolSection.identificationModule.nctId: "NCT01235975"
protocolSection.identificationModule.officialTitle: "Phase IIIb Immunogenicity, Safety and Reactogenicity Study of GSK Biologicals\u0027 Meningococcal Vaccine [GSK 134612] When Given as One Dose to Healthy Subjects Aged 56 Years or Older"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-04-28"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.